Navigation Links
Cephalon Reports Record Earnings and Raises 2010 Guidance
Date:10/28/2010

p>1,252,4221,337,963   LONG-TERM DEBT

384,638363,696   DEFERRED TAX LIABILITIES, net

219,091159,328   OTHER LIABILITIES

279,049111,728Total liabilities

2,135,2001,972,715REDEEMABLE EQUITY

178,245207,307EQUITY:Cephalon Stockholders' Equity   Common stock, $0.01 par value

784780   Additional paid-in capital

2,407,5632,534,070   Treasury stock, at cost

(216,597)(208,427)   Accumulated earnings (deficit)

153,470(178,659)   Accumulated other comprehensive income

164,888114,194Total Cephalon stockholders' equity

2,510,1082,261,958Noncontrolling Interest

62,839216,115Total equity

2,572,9472,478,073$
4,886,392$
4,658,095CEPHALON, INC. AND SUBSIDIARIESCONSOLIDATED STATEMENTS OF CASH FLOWS(In thousands)(Unaudited)Nine Months EndedSeptember 30,20102009CASH FLOWS FROM OPERATING ACTIVITIES:Net income

$
324,278$
210,919Adjustments to reconcile net income to net cash provided by operating activities:Deferred income tax expense (benefit)

(27,976)(40,182)Depreciation and amortization

163,049136,403Stock-based compensation expense

31,74036,710Amortization of debt discount and debt issuance costs

51,31841,273Loss (gain) on foreign exchange contracts

9,499(26,754)Gain on acquisition of Arana

-(10,008)IPR&D from Acusphere deconsolidation

-8,366Other

1,749(5,079)Changes in operating assets and liabilities:Receivables

(1,006)94,204Inventory

31,967(7,060)Other assets

7,48032,206Accounts payable, accrued expenses and deferred revenues

53,39589,192Other liabilities

5,047(43,059)Net cash provided by operating activities

650,540517,131CASH FLOWS FROM INVESTING ACTIVITIES:Purchases of property and equipment

(34,989)(43,647)Proceeds from sale of property and equipment

4,748-Cash balance from consolidation of variable interest entity<
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Drug Sales in the Leukemia Market Will Be Driven By Therapies From Novartis, Bristol-Myers Squibb, Biogen Idec, Roche and Cephalon
2. Cephalon Announces Chairman and CEO to Take Medical Leave of Absence
3. Cephalon Completes Acquisition of Arana Therapeutics
4. Cephalon Appoints Craig C. Phillips as Vice President and General Manager of Oncology Business Unit
5. Cephalon Quarterly Conference Call Invitation
6. Cephalon Prices 5 Million Shares of Common Stock and $435 Million in 2.50% Convertible Senior Subordinated Notes in Public Offerings
7. Cephalon Announces Proposed Public Offering of Common Stock and Convertible Senior Subordinated Notes
8. Cephalons New Product Launches Pace Record 2008 Sales
9. Cephalon Appoints Sarma P. Duddu as General Manager and Vice President of Drug Delivery Technologies for CIMA LABS
10. Cephalon Exercises Option to License Worldwide Rights to ImmuPharma Product, Lupuzor
11. Cephalon and Eurand File Patent Infringement Lawsuit Against Mylan Pharmaceuticals and Barr Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... May 23, 2013 Pusan National University ... private biotherapeutics and contract research company focused on ... cancer, announced today a publication reporting the induction ... the oncolytic and immunotherapeutic vaccinia JX-594 (pexastimogene devacirepvec; ... published in the May 15 th , 2013 ...
(Date:5/23/2013)... May 23, 2013 Watlow®, an ... complete thermal systems, recently introduced its new catalog, ... of experience in designing and manufacturing industrial heaters, ... products to serve diverse customer needs. , A ... at the beginning of the book. These options ...
(Date:5/22/2013)... 2013 iLuv Creative Technology, the premier ... the mobile lifestyle, announces they are now shipping MultiCharger-X, ... multiple iPad devices efficiently. Winner of the 2013 internationally ... Design award, MultiCharger-X is revolutionizing the way businesses, schools, ... deployed. , MultiCharger-X (iAD910) combines the ...
(Date:5/22/2013)... 22, 2013  Superior Controls, Inc. has been ... Business NH Magazine.  For the past 22 years, ... distinguish themselves with extraordinary business and civic excellence. ... this honor," said Rick Pierro ... recognition, this award is a reflection of Superior ...
Breaking Biology Technology:Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 2Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 3Watlow Introduces Its New Industrial Heater Catalog 2iLuv Now Shipping the All New MultiCharger-X 2iLuv Now Shipping the All New MultiCharger-X 3Superior Controls of Seabrook, NH named Business of the Year for 2013 by Business NH Magazine 2
... HOUSTON -- Dec. 17, 2007 -- Using the latest ... physicists has discovered a surprising new electronic property in ... Earth -- lodestone, also known as magnetite. , By ... to get magnetite at temperatures colder than minus 250 ...
... Angiotech Pharmaceuticals,Inc. (NASDAQ: ANPI , TSX: ANP), ... announced that it has submitted a 510(k),application to ... its,innovative, anti-infective 5-Fluorouracil-coated (5-FU) Central Venous,Catheter (CVC)., ... a 510(k) application to,the FDA for our 5-FU ...
... ... Delivery Fleet, LONG ISLAND CITY, N.Y., Dec. 17 FreshDirect, ... today,announced that it has signed a contract with Tri-State Biodiesel to ... of 150 delivery trucks will start the switch to B5, a,blend ...
Cached Biology Technology:New property found in ancient mineral lodestone 2Angiotech Submits 510(K) To FDA For Its Innovative 5-FU CVC 2Angiotech Submits 510(K) To FDA For Its Innovative 5-FU CVC 3Angiotech Submits 510(K) To FDA For Its Innovative 5-FU CVC 4Angiotech Submits 510(K) To FDA For Its Innovative 5-FU CVC 5FreshDirect's Fleet Goes Biodiesel 2FreshDirect's Fleet Goes Biodiesel 3
(Date:5/21/2013)... "place" is increasingly being considered in the management ... new resource that can help them recognize and ... places in their lives. , Place-Based Conservation: ... co-edited by the Pacific Northwest Research Station,s Linda ... to conservation. The book is published by Springer ...
(Date:5/21/2013)... When infections occur in the body, stem cells ... multiplying and differentiating into mature immune cells that ... inflammation can deplete these cell populations, potentially leading ... as cancer. Now, a team of researchers led ... (Caltech) has found that, in mouse models, the ...
(Date:5/21/2013)... University researchers have developed a new method for ... holes in the cell surface. The technique could ... related biological fields. , Bulk electroporation a ... reversible nanopores in the cell membrane that are ... is an increasingly popular method of cell transfection. ...
Breaking Biology News(10 mins):Keeping stem cells strong 2Single-cell transfection tool enables added control for biological studies 2
... a result of increasing levels of atmospheric carbon ... according to Michael Maguire presenting at the Society ... week. Postgraduate researcher Mr Maguire, together with ... they simulated ocean acidification as predicted by current ...
... factors instrumental in triggering latent tuberculosis (TB) infection to ... researchers. New insight into the mystery is provided by ... Microbiology,s spring meeting in Edinburgh today. His work could ... Professor Russell and his group at Cornell University in ...
... surroundings by detecting hormone signals from the host, which ... hormonal messages could be a better way to treat ... good, explains Vanessa Sperandio speaking at the Society for ... bacteria, including harmful strains of Escherichia coli ...
Cached Biology News:Fat clue to TB awakening 2'Hormone therapy' for food poisoning bacteria 2
... CellBIND surface is produced by a patented ... surface giving more consistent, even cell attachment, ... cell attachment and growth uunder difficult conditions, ... CellBIND may provide a more ecominic alternative ...
Mouse polyclonal antibody raised against a partial recombinant RDH5. NCBI Entrez Gene ID = 5959...
The Discovery Series PDQuest 2-D analysis software is used for imaging, analyzing, and databasing two-dimensional electrophoretic gels. The version upgrade allows upgrade of an established version of...
Mouse monoclonal antibody raised against a partial recombinant MYO7A. NCBI Entrez Gene ID = MYO7A...
Biology Products: